Management and Outcomes of Posterior Persistent Fetal Vasculature.


Journal

Ophthalmology
ISSN: 1549-4713
Titre abrégé: Ophthalmology
Pays: United States
ID NLM: 7802443

Informations de publication

Date de publication:
08 2023
Historique:
received: 28 11 2022
revised: 21 03 2023
accepted: 31 03 2023
medline: 24 7 2023
pubmed: 13 4 2023
entrez: 12 4 2023
Statut: ppublish

Résumé

To describe clinical features, management, and outcomes of posterior persistent fetal vasculature (PFV) and suggest a management algorithm. Retrospective, consecutive case series. All children diagnosed with posterior PFV and treated or followed at the Rothschild Foundation Hospital in France between June 2011 and September 2021. Retrospective analysis of the clinical characteristics of posterior PFV. We reported age, gender, presenting symptoms, intraocular pressure, and visual acuity (VA) at diagnosis. Patients were divided into 4 groups depending on the severity and involvement or not of anterior segment. We reported the vitreoretinal surgical techniques used. Anatomic results, ocular hypertension, best-corrected distance visual acuity (BCDVA), presence of postoperative adverse events, and additional surgical interventions were recorded at each follow-up visit. Ninety-six patients were included. The median age at diagnosis was 8 months (IQR = 12), mean 18.9 ± 30.9 months) with a mean follow-up of 27 ± 31.2 months. Although PFV is often an isolated disease, it was associated with a systemic disease in 8% of cases. There was anterior involvement in 62 (64%) of eyes. Forty-one eyes (42.7%) were microphthalmic and more frequently associated with severe PFV (53% vs. 25%; P = 0.01). Surgery was performed in 85 patients (89%). Of them, 69 (81%) had a total success, 5 (6%) had a partial success due to persistent limited peripheral retinal detachment (RD), and 11 (13%) had a failure due to persistent total RD after surgery. Postoperative adverse events occured in 38 eyes including ocular hypertension requiring eye drop medication (7.1%), secondary cell proliferation around the intraocular lens (8.2%), intravitreal hemorrhages (7.1%), and persistent tractional RD (10.6%). Second surgery was performed in 18 patients (21%). At last follow-up, VA could be measured in logarithm of the minimum angle of resolution in 43 children (45%), light perception in 21 eyes (22%), and no light perception or impossible to assess in 32 eyes (33%). In our case series, most patients presenting with posterior PFV received complex vitreoretinal surgery. Goals of the surgery vary and include retinal flattening, reduction of vitreoretinal traction, freeing of visual axis, and aesthetic concerns. We propose a surgical and medical management algorithm for PFV. Proprietary or commercial disclosure may be found after the references.

Identifiants

pubmed: 37044159
pii: S0161-6420(23)00228-2
doi: 10.1016/j.ophtha.2023.03.027
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

844-853

Informations de copyright

Copyright © 2023. Published by Elsevier Inc.

Auteurs

Guy de Saint Sauveur (G)

Pediatric Ophthalmology Department, Rothschild Foundation Hospital, Paris, France.

Thibaut Chapron (T)

Pediatric Ophthalmology Department, Rothschild Foundation Hospital, Paris, France; Université Paris Cité, CRESS, Obstetrical Perinatal and Pediatric Epidemiology Research Team, EPOPé, Paris, France. Electronic address: tchapron@for.paris.

Youssef Abdelmassih (Y)

Pediatric Ophthalmology Department, Rothschild Foundation Hospital, Paris, France.

Ismael Chehaibou (I)

Pediatric Ophthalmology Department, Rothschild Foundation Hospital, Paris, France.

Augustin Lecler (A)

Neuroradiology Department, Rothschild Foundation Hospital, Paris, France.

Pascal Dureau (P)

Pediatric Ophthalmology Department, Rothschild Foundation Hospital, Paris, France.

Florence Metge (F)

Pediatric Ophthalmology Department, Rothschild Foundation Hospital, Paris, France.

Georges Caputo (G)

Pediatric Ophthalmology Department, Rothschild Foundation Hospital, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH